The informative WomensEnews network sends this fine commentary on GlaxoSmithKline's new drug, Alli. Like Olestra, a fine history of which is online at Wikipedia, this is another attempt to make millions off a drug that fuels body-image insecurity, avoids tackling the root causes and, at the end of the day, doesn't even work. Sales are assured.

What I particularly like about this article is the holistic solutions offered at the end - not just 'regulate the unscrupulous drugs industry', but also 'encourage bicycle-friendly architecture'. No surprise - the authors are involved in the excellent Boston Women's Health collective. Now read on... ... read more »

Raj's blog | 1 comment | email this page

Posted on 2 July, 2007 - 23:05